We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 4,512 results
  1. Assessment of potential drug–drug interaction knowledge, attitude, and practice among Egyptian hospital and community pharmacists: a cross-sectional multicenter study

    Background

    Pharmacists have an important role in preventing prescribing errors and providing appropriate information. They can detect potential...

    Engy A. Wahsh, Ahmed E. Abou Warda, ... Eman Mohamed Sadek in Future Journal of Pharmaceutical Sciences
    Article Open access 29 January 2024
  2. Development of a Physiologically Based Pharmacokinetic Population Model for Diabetic Patients and its Application to Understand Disease-drug–drug Interactions

    Introduction

    The activity changes of cytochrome P450 (CYP450) enzymes, along with the complicated medication scenarios in diabetes mellitus (DM)...

    Yafen Li, **aonan Li, ... Dongyang Liu in Clinical Pharmacokinetics
    Article 31 May 2024
  3. Effect of theophylline on stent-related symptoms in patients undergoing Double-J ureteral stent insertion: a randomized controlled trial

    Purpose

    To investigate the effect of oral theophylline on stent-related syndrome (SRS) after Double-J insertion.

    Background

    Double-J stent is widely...

    Alireza Pakdel, Abdolreza Mohammadi, ... Seyed Mohammad Kazem Aghamir in International Urology and Nephrology
    Article 17 April 2024
  4. Salivary Therapeutic Drug Monitoring of Antimicrobial Therapy: Feasible or Futile?

    Personalised drug dosing through therapeutic drug monitoring (TDM) is important to maximise efficacy and to minimise toxicity. Hurdles preventing...

    Lina Davies Forsman, Hannah Ye** Kim, ... Jan-Willem C. Alffenaar in Clinical Pharmacokinetics
    Article Open access 01 February 2024
  5. Therapeutic drug monitoring in inflammatory bowel disease: A practical approach

    The global burden of inflammatory bowel diseases (IBD) is estimated at 4.9 million and the global prevalence exceeds 0.3%. Multiple newer therapeutic...

    Article 08 February 2024
  6. Safety and efficacy of IV theophylline for regadenoson-associated side effect reversal

    Background

    Aminophylline injection has been on an intermittent nation-wide shortage due to manufacturing delays leaving a need for an alternative...

    Courtney Shakowski, Vy A. Pham, ... Robert L. Page II in Journal of Nuclear Cardiology
    Article 07 July 2022
  7. The diuretic effect of adding aminophylline or theophylline to furosemide in pediatric populations: a systematic review

    The diuretic effect of the combined furosemide and aminophylline/theophylline among pediatric patients remains unclear. The primary aim of this...

    Paul Van Siang Lian Mang, Jun Chuen Hui, ... Ka Ting Ng in European Journal of Pediatrics
    Article 17 October 2022
  8. Computational drug repurposing based on electronic health records: a sco** review

    Computational drug repurposing methods adapt Artificial intelligence (AI) algorithms for the discovery of new applications of approved or...

    Nansu Zong, Andrew Wen, ... Hongfang Liu in npj Digital Medicine
    Article Open access 14 June 2022
  9. Intensive care drug therapy and its potential adverse effects on blood pressure and heart rate in critically ill children

    Background

    Owing to complex treatment, critically ill children may experience alterations in their vital parameters. We investigated whether such...

    Lisa Marie Kiesel, Astrid Bertsche, ... Martina Patrizia Neininger in World Journal of Pediatrics
    Article Open access 28 February 2023
  10. Acute Effects of Coffee Consumption on Blood Pressure and Endothelial Function in Individuals with Hypertension on Antihypertensive Drug Treatment: A Randomized Crossover Trial

    Introduction

    Coffee is a complex brew that contains several bioactive compounds and some of them can influence blood pressure (BP) and endothelial...

    Fernanda Barboza de Araujo Lima de Castro, Flávia Garcia Castro, ... Marcia Regina Simas Torres Klein in High Blood Pressure & Cardiovascular Prevention
    Article 01 January 2024
  11. Using a pilot-centric, qualitative drug risk assessment model to identify opportunities for implementing pharmacogenetics

    Background

    Risk assessment models are at the core of flight medicine, weighing both the impact of the flight environment on an aviator and the...

    Jeffrey L. Kinard, Jacob Collie, ... Richard R. Chapleau in Future Journal of Pharmaceutical Sciences
    Article Open access 04 September 2022
  12. Foundations of gastrointestinal-based drug delivery and future developments

    Gastrointestinal-based drug delivery is considered the preferred mode of drug administration owing to its convenience for patients, which improves...

    Jacqueline N. Chu, Giovanni Traverso in Nature Reviews Gastroenterology & Hepatology
    Article 16 November 2021
  13. Volume of Distribution is Unaffected by Metabolic Drug–Drug Interactions

    Introduction

    It has been recognized that significant transporter interactions result in volume of distribution changes in addition to potential...

    Jasleen K. Sodhi, Caroline H. Huang, Leslie Z. Benet in Clinical Pharmacokinetics
    Article 28 July 2020
  14. Impact of a drug-related patient-reported outcome measure on drug-related problem identification, physicians’ acceptance, and clinical and quality of life outcomes: a randomized controlled trial

    Background : Data are scarce regarding the usefulness of a pharmaceutical therapy-related quality of life measure including the Patient-Reported...

    Phantipa Sakthong, Piyaporn Jaisue in International Journal of Clinical Pharmacy
    Article 16 November 2021
  15. Development and assessment of PharmaCheck: an electronic screening tool for the prevention of twenty major adverse drug events

    Background

    Adverse drug events (ADEs) can be prevented by deploying clinical decision support systems (CDSS) that directly assist physicians, via...

    Christian Skalafouris, Jean-Luc Reny, ... Bertrand Guignard in BMC Medical Informatics and Decision Making
    Article Open access 31 May 2022
  16. Management of drug-disease interactions: a best practice from the Netherlands

    Background Drug-disease interactions are situations where pharmacotherapy may have a negative effect on patients’ comorbidities. In these cases, it...

    Maaike M. E. Diesveld, Suzanne de Klerk, ... Sander D. Borgsteede in International Journal of Clinical Pharmacy
    Article 17 July 2021
  17. Herbal Medicine (HM) among pharmacy professionals working in drug retail outlets in Asmara, Eritrea: knowledge, attitude and prevalence of use

    Background

    Globally, the usage of herbal medicines (HMs) is increasingly growing in treating and preventing various ailments. Although, HMs play a...

    Alemseghed Goitom, Feruz Yemane, ... Nuru Abdu in BMC Complementary Medicine and Therapies
    Article Open access 12 August 2022
  18. Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias

    Despite impressive developments in the field of ventricular arrhythmias, there is still a relevant number of patients with ventricular arrhythmias...

    Nawar Alhourani, Julian Wolfes, ... Lars Eckardt in Clinical Research in Cardiology
    Article Open access 14 February 2024
Did you find what you were looking for? Share feedback.